FDA Approves First Covid-19 Vaccine (fda.gov)

Article summary

The FDA has approved the first COVID-19 vaccine, Comirnaty, for individuals 16 years of age and older. The vaccine was previously available under emergency use authorization and has been shown to be 91% effective in preventing COVID-19 disease. The approval is based on a thorough evaluation of the vaccine's safety and effectiveness, including data from a large clinical trial. The vaccine will continue to be available under emergency use authorization for individuals 12 through 15 years of age and for certain immunocompromised individuals.

Main themes

• Vaccine approval
• Vaccination mandates
• Public health
• Government authority
• Individual freedom
• COVID-19 prevention

What commenters say

• Some people are concerned that those who were waiting for full approval to get vaccinated will now find new reasons not to get it.
• Vaccination mandates are likely to become more widespread, including in the US military, now that a vaccine has been fully approved.
• Requiring vaccination as a condition of employment or participation in certain activities is seen as a reasonable measure to protect public health, but others argue it is an overreach of government authority.
• The long-term health outcomes of COVID-19 vaccination are not yet fully understood, which is a concern for some individuals.
• Society has the right to require vaccination as a condition of participation in certain activities, given the overwhelming benefits and minimal risks.
• The use of vaccination mandates and passports may disproportionately affect certain groups, such as low-income communities or communities of color.
• Some individuals believe that the government and corporations are using coercion rather than persuasion to increase vaccination rates.
• The benefits of vaccination outweigh the risks, and it is a necessary measure to protect public health and prevent the spread of COVID-19.